TAILIEUCHUNG - A Pharmacology Primer (Third Edition)

Tham khảo sách 'a pharmacology primer (third edition)', y tế - sức khoẻ, y học thường thức phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả | Methods m Theory Applications THIRD EDITION Primer Elsevier Academic Press 30 Corporate Drive Suite 400 Burlington MA 01803 USA 525 B Street Suite 1900 San Diego California 92101-4495 USA 84 Theobald s Road London WC1X 8RR UK This book is printed on acid-free paper. Copyright 2009 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means electronic or mechanical including photocopy recording or any information storage and retrieval system without permission in writing from the publisher. Permissions may be sought directly from Elsevier s Science Technology Rights Department in Oxford UK phone 44 1865 843830 fax 44 1865 853333 E-mail permissions@. You may also complete your request on-line via the Elsevier homepage http by selecting Customer Support and then Obtaining Permissions. Library of Congress Cataloging-in-Publication Data Kenakin Terrence P. A pharmacology primer theory applications and methods Terry P. Kenakin. -3rd ed. p. cm. Includes bibliographical references and index. ISBN 978-0-12-374585-9 hardcover alk. paper 1. Pharmacology Experimental. I. Title. DNLM 1. Receptors Drug-physiology. 2. Dose-Response Relationship Drug. 3. Pharmacology-methods. QV 38 k33pg 2009 2009 2008040350 British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN 13 978-0-12-374585-9 For all information on all Elsevier Academic Press publications visit our Web site at Printed in China 09 10 987654321 Working together to grow libraries in developing countries I I ELSEVIER Sabre Foundation As always . for .

• Y học thường thức
• Drug Development
• Pharmacometric Modeling
• Disease Progression
• Mechanistic Pharmacokinetic
• Estimation Methods
• of Drug Metabolism
• Drug Metabolite
• Quantitative Drug Metabolism
• Development Processes
• Drug Discovery
• Drug Metabolism
• Medicinal Chemistry
• BMC Bioinformatics
• Drug target relations
• Compound protein relations
• Drug repositioning
• Biological effect
• Molecular histopathology
• Tissue biomarkers in drug
• Diagnostic development
• Final recommendations
• Three companion diagnostic development paths
• Companion diagnostics
• Development of solidified self microemulsifying drug delivery systems containing L tetrahydropalmatine
• Design of experiment approach and bioavailability comparison
• Solidified self microemulsifying drug delivery systems containing L tetrahydropalmatine
• Pellet SMEDDS in the rabbit model
• Cardiovascular pharmacotherapeutics
• Complementarymedicine for preventing
• Treatingcardiovascular disease
• Cardiovascular drug–drug interactions
• Drug treatment of peripheral vascular disorders
• Cardiovascular drugs in development
• Pediatric cardiovascular pharmacology
• Carbohydrate polymers
• Pulmonary drug delivery
• Biodegradable polymer
• Biocompatible polymer
• Drug carrier
• Natural products
• Microbial biocatalysts
• Pharmaceutical products
• Microbial biotransformation
• Drug development based
• Natural products from mevalonic acid pathway
• BMC Musculoskeletal Disorders
• Synovial biopsy
• Rheumatoid arthritis
• Signalling pathways
• Joint deformity
• Principles of pharmacology
• The pathophysiologic basis of drug therapy
• Principles of chemotherapy
• Environmental toxicology
• Frontiers in pharmacology
• Fundamentals of drug development
• Embryonic development
• Zinc chloride
• Zebrafish embryos
• Drug development technologies
• Early life stage
• Polysaccharides for Colon
• Targeted Drug Delivery
• Improved Drug
• Release Specificity
• Therapeutic Benefits
• Factors in Pathogenesis
• RNA interference
• model organisms
• Mucor ciccinelloides
• functional genomics
• human genome
• Illustrated pharmacology for nurse
• Classification and nomenclature of drugs
• Pharmacodynamics of drugs
• Pharmacokinetics of drugs
• Adverse effects of drugs
• Drug interactions
• BMC Pharmacology and Toxicology
• Artemisinin based combination therapy
• Drug resistance
• Sub Saharan Africa
• World Health Organization
• Precision medicine
• Gene regulatory networks
• Biochemical pathways
• Active learning
• Machine learning
• Computational biology
• Materials and methods
• Heterogeneity approaches
• Image analysis tools
• Histopathology in mouse models
• Quantification of blood
• Candidate Drugs
• Toxicity of Microcystins
• Herbal Medicines
• Potential Toxicities
• Animal Models
• inclusive
• comprehensive and ratifiable
• climate change
• inefficient resource
• society organizations
• Environment and Development
• Cytochrome P450
• Interleukin 6
• Monoclonal antibody
• Therapeutic protein–drug interaction
• Multiple cytochrome P450 enzymes
• High performance liquid chromatography
• Drug excipient compatibility
• PDA detector
• Analytical wavelength
• Intermediate precision
• Pluronic – grafted copolymers
• Grafted copolymers as nanoplatforms
• Effectively delivering hydrophobic anticancer drugs
• Innovative development
• Development of an elaa kit to detect neomycin in milk
• Detect neomycin in milk
• Enzyme linked aptamer assay
• Method a variant of ELISA
• Drug resistant infection outbreaks
• capillary electrophoresis
• dodecylcarboxylic acid
• cyclic votammetry
• extrusion technique
• glycerol monooleate
• optical density
• Binding Proteins
• Posttranscriptional Networks
• Biological Macromolecules
• mRNA Stability
• Parasitic Protozoa